Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...

University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells' transportation systems for its own survival.

FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot—lenacapavir—would be given twice a year and ...

With a 500-percent surge in new human immunodeficiency virus or HIV cases per day, the Philippines now has the fastest-growing number of people living with HIV (PLHIV) in the Western Pacific region.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

More than half a million people previously diagnosed with HIV have been started on HIV treatment since the end of February, the health minister says. But can a big jump in 10 weeks really be? We look ...

A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated. Developed by researchers from the Massachusetts Institute of Technology (MIT) and ...

The Philippine National AIDS Council or PNAC has assured people who want to avail themselves of the government’s free HIV testing services that their identities will be kept private.   ...

B.C. experts sound the alarm over rising number of HIV cases With U.S. cuts to programs putting millions at risk, Canada needs to provide leadership to help prevent a resurgence of HIV: expert ...

Quezon City on Sunday said it recorded 421 HIV cases from January to May 2025, 2.43% higher compared to the same period in 2024.

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the young. New research reveals older adults face comparable or higher ...